The COVID-19 pandemic served as a harsh revelation for millions of Americans, exposing the unsettling reality that much of our medical establishment often prioritizes profit over patient care. But as Dr. Peter McCullough emphasizes, the greed that fueled disastrous pandemic policies is hardly limited to viruses—it’s deeply embedded in the fight against cancer too.
The Billion-Dollar Cancer Industry
A recent study in the journal Cancer highlights just how lucrative cancer has become for Big Pharma. Researchers from the University of Calgary found that from 2010 to 2019, annual revenues from cancer drugs rose by 70% among the top ten pharmaceutical companies, while revenues from non-cancer drugs actually fell by 18%.
By 2019, cancer drugs accounted for a staggering 25% of pharmaceutical revenues. Yet troublingly, studies have shown no strong correlation between these skyrocketing prices and actual improvements in patient outcomes. In fact, as drug prices soar past $100,000 per year, fewer and fewer patients can afford the treatments, rendering their “benefits” inaccessible.
A New Hope: Ivermectin and Mebendazole
While Big Pharma focuses on maximizing profits, medical pioneers like Dr. McCullough are working to uncover affordable, safe alternatives for patients battling cancer. His latest research focuses on a surprising candidate: ivermectin, long vilified during the COVID-19 pandemic.
According to a new study published in Acta Poloniae Pharmaceutica – Drug Research, ivermectin shows promising anticancer properties—even in patients undergoing chemotherapy. Preclinical models demonstrate that ivermectin targets cancer through multiple mechanisms, while anecdotal reports suggest meaningful clinical improvements.
Even more promising, when ivermectin is combined with mebendazole—another low-cost, time-tested anti-parasitic—the therapeutic potential increases. Mebendazole, used for over a century to treat parasitic infections, is now being explored for its anticancer properties as well.
Safe, Effective, and Affordable
Unlike the $100,000-per-year chemotherapy regimens that bankrupt families, the ivermectin and mebendazole combination is affordable and accessible. The Wellness Company, backed by Dr. McCullough and other trusted physicians, now offers a high-quality, lab-tested version of this regimen. Their Ivermectin + Mebendazole Parasite Cleanse provides a 90-day supply, carefully compounded in a 50-state licensed pharmacy.
Demand has surged, with the company selling out three times already. Unlike shady overseas pharmacies, The Wellness Company remains the only fully legitimate producer of this innovative therapy in the United States.
Real Stories of Hope
Testimonials are already rolling in from patients and families:
“I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country.” — Jennifer W.
“My daughter started taking ivermectin/mebendazole two weeks ago after being diagnosed with uterine and lung cancers. Her latest biopsy revealed dramatically reduced tumors. Thank you, Doctors, for giving us hope and healing!” — Helen
Fighting for Truth and Real Healing
As Dr. McCullough often reminds us, healthcare should be about saving lives—not inflating shareholder profits. His work stands as a beacon of hope for those seeking safe, effective, and ethical treatments in an industry too often clouded by greed.
In a world where Big Pharma buries anything that threatens its golden goose, courageous doctors and researchers are leading a quiet revolution—one focused on health, not profit
